Collaborations
-

Mike Ferdig, University of Notre Dame, USA
Understanding the emergence, evolution and spread of Plasmodium falciparum antimalarial drug resistance in Africa
-

Jetsumon Sattabongkot, Mahidol University, Thailand
Understanding the creation, persistence and activation of the Plasmodium vivax hypnozoite
-

Manoj Duraisingh, Harvard University, USA
Using Plasmodium falciparum genetic crosses to understand genes governing merozoite invasion of the red blood cell.
-

Jeff Bailey, Brown University, USA
Using Plasmodium falciparum genetic crosses to determine the genetic determinants of reduced sensitivity to lumefantrine.
-

Tim Anderson, Texas Biomedical Research Institute, USA
Using parasite transgenesis to probe the role of the amino acid transporter AAT1 in Plasmodium falciparum parasite fitness on a background of chloroquine resistance
-

Audrey John, University of Pennsylvania, USA
Exploring the role of the Plasmodium falciparum haloacid dehalogenase-like hydrolase, HAD3, in gametocytogenesis and mosquito stage development
-

Kristian Swearingen, Institute for Systems Biology, USA
Investigating the role of glycosylation on the function of the Plasmodium falciparum sporozoite proteins CSP and TRAP
-

Matt Marti, University of Zurich, Switzerland
Using genetic crosses to understand the switch to Plasmodium falciparum gametocytogenesis
-

Kim Lee Sim, Sanaria, USA
Using genetic crosses to create more effective Plasmodium falciparum attenuated parasite vaccines
-

Stefan Kappe, Seattle Children’s Research Institute, USA
Designing CD8 T+ cell dependent malaria vaccines
-

Wai-Hong Tham, Walter and Eliza Hall Institute of Medical Research, Australia
Exploring the role of novel nanobodies as transmission blocking vaccines